학술논문
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study
Document Type
Article
Author
Grande, Enrique; Arranz, José Á; De Santis, Maria; Bamias, Aristotelis; Kikuchi, Eiji; del Muro, Xavier Garcia; Park, Se Hoon; De Giorgi, Ugo; Alekseev, Boris; Mencinger, Marina; Izumi, Kouji; Schutz, Fabio A; Puente, Javier; Li, Jian-Ri; O'Donnell, Peter H; Kalebasty, Arash Rezazadeh; Ye, Dingwei; Mariathasan, Sanjeev; Bene-Tchaleu, FabioIa; Bernhard, Sandrine; Lee, Chooi; Davis, Ian D; Galsky, Matthew D
Source
In The Lancet Oncology January 2024 25(1):29-45
Subject
Language
ISSN
1470-2045